Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system

References

• DesjeuxPLeishmaniasis: current situation and new perspectivesComp Immunol Microbiol Infect Dis200427530531815225981
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO)Control of the Leishmaniases: Report of a Meeting of the 399 WHO Expert Committee on the Control of Leishmaniases, Geneva, 22–26 March 2010WHO 400 Technical Report Series 949GenevaWHO2010 Available from: whqlibdoc.who.int/trs/WHO_TRS_949_eng.pdfAccessed December 18, 2013
   Google Scholar
• AlvarJVélezIDBernCWHO Leishmaniasis Control TeamLeishmaniasis worldwide and global estimates of its incidencePloS One201275e3567122693548
   PubMed Web of Science ®Google Scholar
• CroftSLCoombsGHLeishmaniasis – current chemotherapy and recent advances in the search for novel drugsTrends Parasitol2003191150250814580961
   PubMed Web of Science ®Google Scholar
• GrevelinkSALernerEALeishmaniasisJ Am Acad Dermatol19963422572728642091
   PubMed Web of Science ®Google Scholar
• AnnaloroCOlivaresCUsardiPRetrospective evaluation of amphotericin B deoxycholate toxicity in a single centre series of haematopoietic stem cell transplantation recipientsJ Antimicrob Chemother200963362562619158110
   PubMed Web of Science ®Google Scholar
• DenningDWTherapeutic outcome of invasive aspergillosisClin Infect Dis19962336086158879787
   PubMed Web of Science ®Google Scholar
• BernCAdler-MooreJBerenguerJLiposomal amphotericin B for the treatment of visceral leishmaniasisClin Infect Dis200643791792416941377
   PubMed Web of Science ®Google Scholar
• EggerSSMeierSLeuCDrug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCTBone Marrow Transplant20094571197120319946342
   PubMed Web of Science ®Google Scholar
• ItaliaJLSharpACarterKCWarnPKumarMNPeroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™PLoS One2011610e2574421998690
   PubMed Web of Science ®Google Scholar
• Quintanar-GuerreroDAllémannEFessiHDoelkerEPreparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymersDrug Dev Ind Pharm19982412111311289876569
   PubMed Web of Science ®Google Scholar
• de CarvalhoRFRibeiroIFMiranda-VilelaALLeishmanicidal activity of amphotericin B encapsulated in PLGA-DMSA nanoparticles to treat cutaneous leishmaniasis in C57BL/6 miceExp Parasitol2013135221722223891944
   PubMed Web of Science ®Google Scholar
• AsthanaSJaiswalAKGuptaPKPawarVKDubeAChourasiaMKImmunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsulesAntimicrob Agents Chemother20135741714172223357762
   PubMed Web of Science ®Google Scholar
• ShaoKHuangRLiJAngiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brainJ Control Release2010147111812620609375
   PubMed Web of Science ®Google Scholar
• YangZLLiXRYangKWLiuYAmphotericin B-loaded poly(ethylene glycol)-poly(lactide) micelles: preparation, freeze-drying, and in vitro releaseJ Biomed Mater Res A200885253954617729259
   PubMed Web of Science ®Google Scholar
• KreuterJNanoparticlesSwarbrickJBoylanJCEncyclopedia of Pharmaceutical TechnologyNew York, NYMarcel Dekker1988165190
   Google Scholar
• JanesKAFresneauMPMarazuelaAFabraAAlonsoMJChitosan nanoparticles as delivery systems for doxorubicinJ Control Release2001732–325526711516503
   PubMed Web of Science ®Google Scholar
• St JohnALChanCYStaatsHFLeongKWAbrahamSNSynthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodesNat Mater201211325025722266469
   PubMed Web of Science ®Google Scholar
• HuangLSuiWWangYJiaoQPreparation of chitosan/chondroitin sulfate complex microcapsules and application in controlled release of 5-fluorouracilCarbohydr Polym2010801168173
   Web of Science ®Google Scholar
• Ganza-GonzálezAAnguiano-IgeaSOtero-EspinarFJBlanco MéndezJChitosan and chondroitin microspheres for oral-administration controlled release of metoclopramideEur J Pharm Biopharm199948214915510469933
   PubMed Web of Science ®Google Scholar
• SuiWHuangLWangJBoQPreparation and properties of chitosan chondroitin sulfate complex microcapsulesColloids Surf B Biointerfaces2008651697318440788
   PubMed Web of Science ®Google Scholar
• YehMKChengKMHuCSHuangYCYoungJJNovel protein-loaded chondroitin sulfate-chitosan nanoparticles: preparation and characterizationActa Biomater20117103804381221742066
   PubMed Web of Science ®Google Scholar
• HuCSChiangCHHongPDYehMKInfluence of charge on FITC-BSA-loaded chondroitin sulfate-chitosan nanoparticles upon cell uptake in human Caco-2 cell monolayersInt J Nanomedicine201274861487223028215
   PubMed Web of Science ®Google Scholar
• TsaiHYChiuCCLinPCChenSHHuangSJWangLFAntitumor efficacy of doxorubicin released from crosslinked nanoparticulate chondroitin sulfate/chitosan polyelectrolyte complexesMacromol Biosci201111568068821360679
   PubMed Web of Science ®Google Scholar
• BhattaraiNGunnJZhangMChitosan-based hydrogels for controlled, localized drug deliveryAdv Drug Deliv Rev2010621839919799949
   PubMed Web of Science ®Google Scholar
• ThongngamMMcClementsDJInfluence of pH, ionic strength, and temperature on self-association and interactions of sodium dodecyl-sulfate in the absence and presence of chitosanLangmuir2005211798615620287
   PubMed Web of Science ®Google Scholar
• IovuMDumaisGdu SouichPAnti-inflammatory activity of chondroitin sulfateOsteoarthritis Cartilage200816Suppl 3S14S1818667340
   PubMed Web of Science ®Google Scholar
• RoncaFPalmieriLPanicucciPRoncaGAnti-inflammatory activity of chondroitin sulfateOsteoarthritis Cartilage19986Suppl A14219743814
   PubMed Web of Science ®Google Scholar
• RoncaFPalmieriLPanicucciPRoncaGAnti-inflammatory activity of chondroitin sulfateOsteoarthritis Cartigale19986A1421
   PubMedGoogle Scholar
• KirkerKRLuoYMorrisSEShelbyJPrestwichGDGlycosaminoglycan hydrogels as supplemental wound dressings for donor sitesJ Burn Care Rehab2004253276286
   PubMedGoogle Scholar
• KirkerKRLuoYNielsonJHShelbyJPrestwichGDGlycosaminoglycan hydrogel films as bio-interactive dressings for wound healingBiomaterials200223173661367112109692
   PubMed Web of Science ®Google Scholar
• WangLFWangJMChiangYLInsolubilization of sodium chondroitin sulfate by forming a semi-interpenetrating polymer network with acrylic acid: a potential carrier for colon-specific drug deliveryJ Appl Polym Sci2002851114122
   Web of Science ®Google Scholar
• SintovADi-CapuaNRubinsteinACross-linked chondroitin sulphate: characterization for drug delivery purposesBiomaterials19951664734787654874
   PubMed Web of Science ®Google Scholar
• CostaDFFrancaJRRibeiroTGKaplanMAFaracoAACastilhoRODevelopment and characterization of polymeric nanoparticles as Barbatimão (Stryphnodendron obovatum) standardized fraction carrierAdv Biosci Biotechnol2012418992
   Google Scholar
• CalvoPRemuñán-LópezCVila-JatoJLAlonsoMJNovel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriersJ Appl Polym Sci1997631125132
   Web of Science ®Google Scholar
• GrenhaAGomesMERodriguesMDevelopment of new chitosan/carrageenan nanoparticles for drug delivery applicationsJ Biomed Mater Res A20109241265127219322874
   PubMed Web of Science ®Google Scholar
• MüllerRHSchmidtSButtleIAkkarASchmittJBrömerSSolEmuls-novel technology for the formulation of iv emulsions with poorly soluble drugsInt J Pharm2004269229330214706241
   PubMedGoogle Scholar
• MorenoMAFrutosPBallesterosMPLyophilized lecithin based oil-water microemulsions as a new and low toxic delivery system for amphotericin BPharm Res200118334435111442275
   PubMed Web of Science ®Google Scholar
• SantosCMOliveiraRBArantesVTAmphotericin B-loaded nanocarriers for topical treatment of cutaneous leishmaniasis: development, characterization, and in vitro skin permeation studiesJ Biomed Nanotechnol20128232232922515084
   PubMed Web of Science ®Google Scholar
• NaharMJainNKPreparation, characterization and evaluation of targeting potential of amphotericin B-loaded engineered PLGA nanoparticlesPharm Res200926122588259819842021
   PubMed Web of Science ®Google Scholar
• CoelhoEATavaresCACarvalhoFAImmune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infectionInfect Immun20037173988399412819086
   PubMed Web of Science ®Google Scholar
• ValadaresDGDuarteMCOliveiraJSLeishmanicidal activity of the Agaricus blazei Murill in different Leishmania speciesParasitol Int201160435736321723957
   PubMed Web of Science ®Google Scholar
• FumarolaLSpinelliRBrandonisioOIn vitro assays for evaluation of drug activity against Leishmania sppRes Microbiol2004155422423015142618
   PubMed Web of Science ®Google Scholar
• LöfgrenSEMilettiLCSteindelMBachèreEBarraccoMATrypanocidal and leishmanicidal activities of different antimicrobial peptides (AMPs) isolated from aquatic animalsExp Parasitol2008118219720217888907
   PubMed Web of Science ®Google Scholar
• JungSHLimDHJungSHAmphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristicsEur J Pharm Sci2009373–431332019491021
   PubMed Web of Science ®Google Scholar
• OnishiHMachidaYBiodegradation and distribution of water-soluble chitosan in miceBiomaterials199920217518210022787
   PubMed Web of Science ®Google Scholar
• HuangMMaZKhorELimLYUptake of FITC-chitosan nanoparticles by A549 cellsPharm Res200219101488149412425466
   PubMed Web of Science ®Google Scholar
• AdamsMLKwonGSRelative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles: effects of acyl chain lengthJ Control Release2003871–3233212618020
   PubMed Web of Science ®Google Scholar
• TasdemirDKaiserMBrunRAntitrypanosomal and anti-leishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studiesAntimicrob Agents Chemother20065041352136416569852
   PubMed Web of Science ®Google Scholar
• PujalsGSuñé-NegreJMPérezPIn vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantumParasitol Res200810261243124718278586
   PubMed Web of Science ®Google Scholar
• NakajimaAShinodaKComplex formation between oppositely charged polysaccharidesJ Colloid Interface Sci1976551126132
   Web of Science ®Google Scholar
• ChenWBWangLFChenJSFanSYCharacterization of polyelectrolyte complexes between chondroitin sulfate and chitosan in the solid stateJ Biomed Mater Res A200575112813716041796
   PubMedGoogle Scholar
• MazerskiJGrzybowskaJBorowskiEInfluence of net charge on the aggregation and solubility behaviour of amphotericin B and its derivatives in aqueous mediaEur Biophys J19901831591642357943
   PubMedGoogle Scholar
• BatrakovaEVGendelmanHEKabanovAVCell-mediated drug deliveryExpert Opin Drug Deliv20118441543321348773
   PubMed Web of Science ®Google Scholar
• Danesh-BahreiniMAShokriJSamieiAKamali-SarvestaniEBarzegar-JalaliMMohammadi-SamaniSNanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c miceInt J Nanomedicine2011683584221589651
   PubMed Web of Science ®Google Scholar
• WiseDLHandbook of Pharmaceutical Controlled Release TechnologyNew York, NYMarcel Dekker2000 Chap 9183210
   Google Scholar
• JoganiVJinturkarKVyasTMisraARecent patents review on intranasal administration for CNS drug deliveryRecent Pat Drug Deliv Formul200821254019075895
   PubMedGoogle Scholar
• LegrandPRomeroEACohenBEBolardJEffects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytesAntimicrob Agents Chemother19923611251825221489196
   PubMed Web of Science ®Google Scholar
• DarolePSHegdeDDNairHAFormulation and evaluation of microemulsion based delivery system for amphotericin BAAPS Pharm Sci Tech200891122128
   PubMed Web of Science ®Google Scholar
• Van de VenHPaulussenCFeijensPBPLGA nanoparticles and nanosuspensions with amphotericin B: Potent in vitro and in vivo alternatives to Fungizone and AmBisomeJ Control Release2012161379580322641062
   PubMed Web of Science ®Google Scholar
• CorwareKHarrisDTeoIAccelerated healing of cutaneous leishmaniasis in non-healing BALB/c mice using water soluble amphotericin B-polymethacrylic acidBiomaterials20112318029803921807409
   PubMedGoogle Scholar